Skip to main content
Beat Cancer EU Website Logo
Obstacles à l'obtention de soins de suivi chez les survivants du cancer de l'enfant
Suivi à long termeAllArticle

Obstacles à l'obtention de soins de suivi chez les survivants du cancer de l'enfant

Cet article identifie les obstacles auxquels les survivants d'un cancer de l'enfant peuvent être confrontés lorsqu'il s'agit de soins de suivi à long terme.

Année :2023

Barriers to Receiving Follow-up Care Among Childhood Cancer SurvivorsLittle is known on why adherence to follow-up care in childhood cancer survivors (CCS) is lacking. This study characterized barriers to adherence to follow-up care among CCS, identified sociodemographic correlates of barriers, and examined whether barriers to follow-up care relate to health-related quality of life. Adult CCS (N=84) were anonymously surveyed via REDCap using the Barriers to Care Questionnaire (BCQ) and the Quality of Life Scale-Cancer Survivor (QOL-CS).

Both descriptive and correlation analyses were conducted. The median BCQ total score was 88.5 (interquartile ranges: 78.4 to 95.7), with the greatest barriers reported in the Skills (eg, ease of navigating the healthcare system) and Pragmatism subscales (eg, cost). There was a statistically significant correlation between the BCQ total score and the QOL-CS total score (rs=0.47, P <0.0001) and the physical, psychological, and social QOL-CS subscales (all P ‘s<0.05).

The results found that barriers to follow-up care for CCS are mostly related to cost and appointment logistics, and that more barriers to care is associated with lower health-related quality of life among CCS. Identifying barriers to follow-up care is the first step in improving adherence, which would allow for earlier detection of late effects of cancer therapy and thereby result in reductions in morbidity and mortality.

Discussion & Questions

Remarque : Les commentaires servent uniquement à la discussion et à la clarification. Pour des conseils médicaux, veuillez consulter un professionnel de santé.

Laisser un commentaire

Minimum 10 caractères, maximum 2000 caractères

Aucun commentaire pour le moment

Soyez le premier à partager vos réflexions !